When people hear “Jewish genetic diseases,” they often think of Ashkenazi Jews (Eastern European background) — with conditions like Tay-Sachs, Canavan, and Gaucher.
But the story is much broader. Jewish populations are wonderfully diverse, and each community has its own carrier risks.
Sephardi Jews (from Spain, Portugal, North Africa, Middle East):
-
Familial Mediterranean Fever (FMF)
-
Beta-thalassemia
-
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
Mizrahi Jews (Middle Eastern, Iraqi, Yemenite):
-
Beta-thalassemia and sickle cell disease
-
G6PD deficiency
-
Various metabolic disorders
Persian Jews (Iranian heritage):
Persian Jews, one of the oldest continuous Jewish communities, also carry distinct genetic risks that make screening especially important.
-
Pseudocholinesterase deficiency: an enzyme disorder that can cause life-threatening complications during anesthesia.
-
Polyglandular autoimmune syndromes: conditions affecting multiple hormone-producing glands.
-
Other recessive conditions that are less common elsewhere but appear more frequently in the Persian Jewish population due to historical isolation and endogamy.
Why this matters:
-
If you identify as Sephardi, Mizrahi, or Persian, don’t assume carrier screening is “less relevant.”
-
Many panels today are “pan-ethnic” — meaning they cover a broad range of conditions across all backgrounds.
-
Knowing your heritage can help your provider tailor recommendations and interpret results.
The bigger picture:
Carrier screening started in Ashkenazi communities, but it’s now understood as a tool for everyone. Whether your roots are Eastern European, Moroccan, Persian, or a mix of many, screening empowers you with knowledge.
Takeaway: Jewish genetic health is a tapestry of Ashkenazi, Sephardi, Mizrahi, and Persian threads. Screening helps ensure every strand is honored and protected.